Krka DD (LTS:0HLK) Inventories, Raw Materials & Components: €242 Mil (As of Mar. 2026)


LTS:0HLK Krka DD LTS:0HLK
84 GF Score
Price €64.80
GF Value €41.97
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD Inventories, Raw Materials & Components?

Krka DD LTS:0HLK 84 Inventories, Raw Materials & Components is €242 Mil as of Mar. 2026. GuruFocus rates LTS:0HLK with a GF Score™ of 84/100 and a GF Value™ of €41.97 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Krka DD's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €242 Mil.

Krka DD's quarterly raw materials declined from Sep. 2025 (€260 Mil) to Dec. 2025 (€255 Mil) and declined from Dec. 2025 (€255 Mil) to Mar. 2026 (€242 Mil).

Krka DD's annual raw materials increased from Dec. 2023 (€265 Mil) to Dec. 2024 (€266 Mil) but then declined from Dec. 2024 (€266 Mil) to Dec. 2025 (€255 Mil).

Krka DD Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Krka DD's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Inventories, Raw Materials & Components Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.99 230.09 265.02 266.40 254.81

Krka DD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 262.51 253.44 260.24 254.81 242.47
LTS:0HLK
84GF Score
Krka DD LTS:0HLK
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €242 Mil mean?
Krka DD (LTS:0HLK) has a Inventories, Raw Materials & Components of €242 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Krka DD and its competitors.
Is Krka DD's Inventories, Raw Materials & Components too high?
Krka DD's current Inventories, Raw Materials & Components is €242 Mil. Overall, Krka DD has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Krka DD's Inventories, Raw Materials & Components of €242 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Krka DD and its competitors. Krka DD's current Inventories, Raw Materials & Components is €242 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (LTS:0HLK) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.97, compared to a current price of €64.80 — trading 54.4% above its estimated fair value. The current Inventories, Raw Materials & Components is €242 Mil. Krka DD's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Krka DD (LTS:0HLK), the current Inventories, Raw Materials & Components is €242 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (LTS:0HLK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €64.80 is trading 54.4% above its estimated GF Value™ of €41.97. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for LTS:0HLK:

  • Inventories, Raw Materials & Components: €242 Mil
  • GF Value™: €41.97 vs. price of €64.80 (54.4% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HLK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
84GF Score

Get the complete analysis for LTS:0HLK

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.80
Price
€41.97
GF Value